BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28121350)

  • 21. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.
    Li CH; Liu CW; Tsai CH; Peng YJ; Yang YH; Liao PL; Lee CC; Cheng YW; Kang JJ
    Arch Toxicol; 2017 May; 91(5):2165-2178. PubMed ID: 27752740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers.
    Wu CT; Chang YJ; Chen MF; Liu JJ; Wei PL; Wang W; Liu HH
    Tumour Biol; 2014 Jun; 35(6):6047-54. PubMed ID: 24633886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients.
    Yauch RL; Januario T; Eberhard DA; Cavet G; Zhu W; Fu L; Pham TQ; Soriano R; Stinson J; Seshagiri S; Modrusan Z; Lin CY; O'Neill V; Amler LC
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8686-98. PubMed ID: 16361555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2.
    Zhao D; Han W; Liu X; Cui D; Chen Y
    Thorac Cancer; 2017 Jul; 8(4):320-327. PubMed ID: 28509438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
    Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
    Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
    Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
    Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human NANOS3 gene contributes to lung tumour invasion by inducing epithelial-mesenchymal transition.
    Grelet S; Andries V; Polette M; Gilles C; Staes K; Martin AP; Kileztky C; Terryn C; Dalstein V; Cheng CW; Shen CY; Birembaut P; Van Roy F; Nawrocki-Raby B
    J Pathol; 2015 Sep; 237(1):25-37. PubMed ID: 25904364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer.
    Chen X; Guan X; Zhang H; Xie X; Wang H; Long J; Cai T; Li S; Liu Z; Zhang Y
    J Exp Clin Cancer Res; 2015 Jan; 34(1):3. PubMed ID: 25609022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.
    Rho JK; Choi YJ; Lee JK; Ryoo BY; Na II; Yang SH; Kim CH; Lee JC
    Lung Cancer; 2009 Feb; 63(2):219-26. PubMed ID: 18599154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multi-channel promotion of lung cancer progress by bone marrow derived mesenchymal stem cells in tumor microenvironment].
    Luo D; Hu SY; Liu GX
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):85-91. PubMed ID: 29502366
    [No Abstract]   [Full Text] [Related]  

  • 32. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition.
    Duan Q; Pang C; Chang N; Zhang J; Liu W
    Oncol Rep; 2016 Jul; 36(1):551-8. PubMed ID: 27176594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.
    Xiong Y; Liu Y; Xiong W; Zhang L; Liu H; Du Y; Li N
    Hum Reprod; 2016 Jun; 31(6):1327-38. PubMed ID: 27094478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.
    Aruga N; Kijima H; Masuda R; Onozawa H; Yoshizawa T; Tanaka M; Inokuchi S; Iwazaki M
    Tokai J Exp Clin Med; 2018 Apr; 43(1):5-13. PubMed ID: 29637533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nicotine Induced Lung Cancer Cells Epithelial-mesenchymal Transition 
and Promote Its Vitro Invasion Potential].
    Hou Y; Li X; Pan Z; Zu L; Fan Y; You J; Wang Y; Wang M; Chen P; Shen W; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):169-76. PubMed ID: 27118643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
    Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
    Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-760 mediates chemoresistance through inhibition of epithelial mesenchymal transition in breast cancer cells.
    Hu SH; Wang CH; Huang ZJ; Liu F; Xu CW; Li XL; Chen GQ
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):5002-5008. PubMed ID: 27981531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition.
    Qian YR; Guo Y; Wan HY; Fan L; Feng Y; Ni L; Xiang Y; Li QY
    Oncol Rep; 2013 Jun; 29(6):2408-14. PubMed ID: 23545945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.